| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.6 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |